120 related articles for article (PubMed ID: 15112683)
21. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
Hale ME; Dvergsten C; Gimbel J
J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
[TBL] [Abstract][Full Text] [Related]
22. Economic study on the impact of side effects in patients taking oxycodone controlled-release for noncancer pain.
Anastassopoulos KP; Chow W; Tapia CI; Baik R; Ackerman SJ; Biondi D; Kim MS
J Manag Care Pharm; 2012 Oct; 18(8):615-26. PubMed ID: 23127149
[TBL] [Abstract][Full Text] [Related]
23. The Effectiveness of Intravenous Oxycodone in the Treatment of Acute Postoperative Pain: A Systematic Review.
Tan HP; Conroy T
J Perianesth Nurs; 2018 Dec; 33(6):865-879. PubMed ID: 30449435
[TBL] [Abstract][Full Text] [Related]
24. Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia.
Silvasti M; Rosenberg P; Seppälä T; Svartling N; Pitkänen M
Acta Anaesthesiol Scand; 1998 May; 42(5):576-80. PubMed ID: 9605375
[TBL] [Abstract][Full Text] [Related]
25. A retrospective comparison of intrathecal morphine and epidural hydromorphone for analgesia following posterior spinal fusion in adolescents with idiopathic scoliosis.
Hong RA; Gibbons KM; Li GY; Holman A; Voepel-Lewis T
Paediatr Anaesth; 2017 Jan; 27(1):91-97. PubMed ID: 27878902
[TBL] [Abstract][Full Text] [Related]
26. Controlled Release of Oxycodone as an Opioid Titration for Cancer Pain Relief: A Retrospective Study.
Zhao S; Xu C; Lin R
Med Sci Monit; 2020 Mar; 26():e920598. PubMed ID: 32225127
[TBL] [Abstract][Full Text] [Related]
27. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
[TBL] [Abstract][Full Text] [Related]
28. A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.
Nosek K; Leppert W; Nosek H; Wordliczek J; Onichimowski D
Drug Des Devel Ther; 2017; 11():2409-2419. PubMed ID: 28860712
[TBL] [Abstract][Full Text] [Related]
29. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy.
Watson CP; Moulin D; Watt-Watson J; Gordon A; Eisenhoffer J
Pain; 2003 Sep; 105(1-2):71-8. PubMed ID: 14499422
[TBL] [Abstract][Full Text] [Related]
30. Controlled-release oxycodone and morphine in cancer related pain.
Heiskanen T; Kalso E
Pain; 1997 Oct; 73(1):37-45. PubMed ID: 9414055
[TBL] [Abstract][Full Text] [Related]
31. Safety and tolerability of controlled-release oxycodone on postoperative pain in patients submitted to the oncologic head and neck surgery.
Cavalcanti IL; Carvalho AC; Musauer MG; Rodrigues VS; Migon RN; Figueiredo NV; Vane LA
Rev Col Bras Cir; 2014; 41(6):393-9. PubMed ID: 25742404
[TBL] [Abstract][Full Text] [Related]
32. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial.
Gimbel JS; Richards P; Portenoy RK
Neurology; 2003 Mar; 60(6):927-34. PubMed ID: 12654955
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of controlled-release oxycodone 20 mg administered on a 12-h dosing schedule on the management of postoperative pain after breast surgery for cancer.
Kampe S; Warm M; Kaufmann J; Hundegger S; Mellinghoff H; Kiencke P
Curr Med Res Opin; 2004; 20(2):199-202. PubMed ID: 15006014
[TBL] [Abstract][Full Text] [Related]
34. A comparison of oxycodone prolonged-release vs. oxycodone + naloxone prolonged-release after laparoscopic hysterectomy.
Comelon M; Wisloeff-Aase K; Raeder J; Draegni T; Undersrud H; Qvigstad E; Bjerkelund CE; Lenz H
Acta Anaesthesiol Scand; 2013 Apr; 57(4):509-17. PubMed ID: 23301686
[TBL] [Abstract][Full Text] [Related]
35. A comparison of intravenous oxycodone and intravenous morphine in patient-controlled postoperative analgesia after laparoscopic hysterectomy.
Lenz H; Sandvik L; Qvigstad E; Bjerkelund CE; Raeder J
Anesth Analg; 2009 Oct; 109(4):1279-83. PubMed ID: 19762758
[TBL] [Abstract][Full Text] [Related]
36. [Controlled-release oxycodone in the treatment of chronic musculoskeletal pain: A preliminary experience of rheumatology center].
Grazio S; Grubišić F; Knež V; Kavanagh HS; Nemčić T
Reumatizam; 2016; 63(1):20-3. PubMed ID: 29616539
[TBL] [Abstract][Full Text] [Related]
37. Relative potency of controlled-release oxycodone and controlled-release morphine in a postoperative pain model.
Curtis GB; Johnson GH; Clark P; Taylor R; Brown J; O'Callaghan R; Shi M; Lacouture PG
Eur J Clin Pharmacol; 1999 Aug; 55(6):425-9. PubMed ID: 10492054
[TBL] [Abstract][Full Text] [Related]
38. [Effective pain relief facilitates exercise therapy : Results of a multicenter study with controlled-release oxycodone in patients with movement pain].
Teske W; Anastasiadis A; Krämer J; Theodoridis T
Orthopade; 2008 Dec; 37(12):1210-6. PubMed ID: 18806997
[TBL] [Abstract][Full Text] [Related]
39. Comparison of controlled-release and immediate-release oxycodone tablets in patients with cancer pain.
Kaplan R; Parris WC; Citron ML; Zhukovsky D; Reder RF; Buckley BJ; Kaiko RF
J Clin Oncol; 1998 Oct; 16(10):3230-7. PubMed ID: 9779696
[TBL] [Abstract][Full Text] [Related]
40. Fixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer pain.
Simpson K; Leyendecker P; Hopp M; Müller-Lissner S; Löwenstein O; De Andrés J; Troy Ferrarons J; Bosse B; Krain B; Nichols T; Kremers W; Reimer K
Curr Med Res Opin; 2008 Dec; 24(12):3503-12. PubMed ID: 19032132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
